ADORA2A rs4846050: Caffeine Sensitivity and Sleep Patterns
The rs4846050 variant is a single nucleotide polymorphism located within the ADORA2A gene, which encodes the adenosine A2A receptor. Research suggests this variant may influence how individuals respond to caffeine, specifically regarding sleep quality, sleep latency, and caffeine-induced insomnia.
What each genotype means
Typical caffeine sleep sensitivity
Carriers of the CC genotype typically experience standard baseline sensitivity to caffeine-induced sleep disruption, with research showing fewer reported alterations in slow-wave sleep depth following moderate caffeine intake. However, evidence connecting this regulatory variant to caffeine response and anxiety-related insomnia remains limited and is influenced by broader linkage across the ADORA2A gene locus. Individuals sensitive to sleep disturbances should observe personal caffeine tolerance and speak to a clinician or pharmacist regarding any sleep-modulating medications.
Carried by approximately 30% of European and East Asian individuals.
Intermediate caffeine sleep disruption
Carrying one copy of the T allele is associated with an intermediate or moderately elevated sensitivity to caffeine-related sleep disturbances, such as reductions in deep slow-wave sleep. Because current published evidence for rs4846050 is limited and exhibits linkage disequilibrium with other ADORA2A polymorphisms (such as rs5751876), real-world physiological effects may vary across individuals. Anyone experiencing caffeine-associated sleep disruption or considering medication adjustments should consult with a healthcare professional.
Present in roughly 49% of European and East Asian populations, representing the most common genotype.
Heightened caffeine sleep disruption
Individuals with two copies of the T allele have been linked in preliminary studies to increased vulnerability to caffeine-induced sleep disruption, lighter non-REM sleep, and higher rates of caffeine-associated restlessness. Because scientific associations for rs4846050 remain limited and mixed across broader cohorts, this genotype does not guarantee insomnia or heightened anxiety. If you have concerns about caffeine consumption, persistent insomnia, or sleep-altering medications, consider discussing management strategies with your physician or pharmacist.
Found in approximately 20% to 21% of European and East Asian individuals.
Understanding the rs4846050 Variant
The rs4846050 variant is a specific genetic change located within the ADORA2A gene on chromosome 22. In genetics, a single nucleotide polymorphism (SNP) like rs4846050 represents a variation at a single position in the DNA sequence. This particular SNP is situated in a region of the genome that regulates the expression and function of the adenosine A2A receptor. Because this receptor is a primary target for caffeine in the human brain, variations in the gene that codes for it are of significant interest to researchers studying why people react differently to stimulants. While rs4846050 is often studied alongside other nearby variants in the ADORA2A gene, it serves as a marker for understanding the biological pathways that link caffeine consumption to physiological outcomes like wakefulness and sleep architecture.
The Role of the ADORA2A Gene
The ADORA2A gene provides instructions for creating the adenosine A2A receptor, a protein found on the surface of cells throughout the body, including the brain. Adenosine is a chemical that naturally builds up in the brain throughout the day, promoting sleepiness by binding to these receptors. Caffeine functions as an adenosine receptor antagonist, meaning it blocks adenosine from binding to the A2A receptor, thereby preventing the signal that tells the brain it is time to sleep. By inhibiting this pathway, caffeine promotes alertness and wakefulness. Genetic variations in ADORA2A can potentially alter the density, sensitivity, or expression of these receptors. Consequently, individuals with different genotypes may experience varying degrees of caffeine-induced wakefulness or sensitivity to the stimulant's effects on their ability to fall and stay asleep.
Research and Evidence Strength
Scientific evidence linking ADORA2A variants to caffeine-related sleep traits is considered limited and often context-dependent. Multiple studies have observed that certain ADORA2A genotypes correlate with self-reported caffeine sensitivity, sleep disturbances, and changes in brain electrical activity during sleep. However, these associations are complex and can be influenced by the total amount of daily caffeine consumed. For instance, some research indicates that the impact of these genetic variants is more pronounced in individuals with low-to-moderate caffeine intake compared to high consumers. Furthermore, because many SNPs in the ADORA2A region are in strong linkage disequilibrium—meaning they are inherited together—it is often difficult to determine if rs4846050 is the direct functional cause of these traits or simply a marker for other nearby genetic changes. Current findings should be viewed as statistical associations rather than definitive predictors of individual behavior.
Population Frequency
The rs4846050 variant is relatively common, with a minor allele frequency (MAF) of approximately 0.45 across both European and Asian populations. This high frequency indicates that the variant is widely distributed and that a significant portion of the population carries at least one copy of the minor allele.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs4846050 provide only a small piece of the puzzle regarding how your body processes caffeine. Sleep quality is a complex trait influenced by a wide array of factors, including overall lifestyle, stress levels, environment, and the interaction of many different genes. Having a specific genotype does not guarantee that you will experience caffeine-induced insomnia or, conversely, that you are immune to the effects of coffee. This information is intended for educational purposes and should not be used to make medical decisions or self-diagnose sleep disorders. If you are concerned about your sleep quality, the impact of caffeine on your health, or if you are considering changes to your medication or supplement regimen, please consult with a qualified healthcare professional or a registered dietitian who can provide personalized guidance based on your complete health history.
How common is this variant?
The rs4846050 variant is common, with a minor allele frequency of approximately 0.45 across European and Asian populations.
Frequently asked questions
Does my ADORA2A genotype mean I should stop drinking coffee?
No, your genotype does not dictate your caffeine intake. Genetic associations are statistical trends, not medical advice, and you should base your caffeine consumption on how you personally feel and your own sleep quality.
Can a DNA test tell me if I have insomnia?
No. Insomnia is a complex clinical condition diagnosed by healthcare providers based on symptoms and medical history. Genetic variants like rs4846050 only indicate a potential predisposition to certain traits, not a diagnosis.
Are all ADORA2A variants the same?
No, the ADORA2A gene contains many different SNPs. While some are linked to caffeine sensitivity, they function differently, and researchers often study them in groups to understand their combined effects.
Why do studies show different results for caffeine sensitivity?
Caffeine sensitivity is influenced by many factors, including age, sex, total daily caffeine intake, and other genetic variants. Differences in study design and population demographics often lead to varying conclusions.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4846050?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADORA2A
The T allele of this variant is associated with increased caffeine-induced anxiety and sleep disturbances.
This variant is associated with individual differences in caffeine sensitivity and sleep patterns.
Functional regulatory variant modulating adenosine A2A receptor transcription, sleep EEG slow-wave power, and caffeine-induced sleep disruption.
An adenosine A2A receptor variant that alters sensitivity to caffeine-induced anxiety, panic symptoms, and sleep architecture disruption.
A synonymous polymorphism tightly linked to rs1801175 in ADORA2A that modulates caffeine-provoked panic disorder susceptibility and electroencephalographic arousal.